Window to Japan
https://bio.nikkeibp.co.jp/atcl/news/p1/24/03/29/11755/ The company filed a clinical trial application (IND) in
https://bio.nikkeibp.co.jp/atcl/news/p1/24/03/29/11757/ The company’s basic technology involves introducing an animal reprogramming
https://bio.nikkeibp.co.jp/atcl/news/p1/24/02/29/11648/ Yamaguchi University’s Institute for Cell Design and Medical Science
https://bio.nikkeibp.co.jp/atcl/news/p1/24/03/02/11654/ Seven Japanese companies have initiated an “Intestinal Design Co-Creation
https://pubs.acs.org/doi/10.1021/acscatal.4c00487 Sortases are prokaryotic enzymes that modify surface proteins by recognizing
https://www.nedo.go.jp/content/100972177.pdf The announced budget is 44.5 billion yen (– 275
https://bio.nikkeibp.co.jp/atcl/report/16/082400016/012500325/ Nikkei Biotech has reviewed the biotech budgets of the
https://www.nedo.go.jp/news/press/AA5_101720.html As part of the NEDO-funded “International Collaborative Research and
https://bio.nikkeibp.co.jp/atcl/column/16/052700070/011500024/ An excellent review up to the end of 2023
https://www.nedo.go.jp/news/press/AA5_101721.html In Japan, approximately 8 million tons or approximately 20%